Value of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation.

Clin Res Cardiol · 2018 · PMC6244978 · PMID 29797054

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an obvious trendno p-value reported

did not reach statistical significanceno p-value reported

There was an obvious trend that the predictive power for new-onset or recurrent stroke/TIA of the Fabry-specific score is superior to the CHA 2 DS 2 -VASc score, although this trend did not reach statistical significance in this FD cohort (AUC 0.87, 95% CI 0.79–0.94 vs.

also in 1,006 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.